Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALGeneric

PINDAC

PINACIDIL

Standard Dose
12.5MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview PINDAC is listed in Drugs@FDA under application 019456 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient PINACIDIL Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 12.5MG Sponsor LEO PHARM Submission history Latest submission status date: 1989-12-28 00:00:00.

Structured Monograph

Clinical summary

Approval overview PINDAC is listed in Drugs@FDA under application 019456 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient PINACIDIL Form and strength CAPSULE, EXTENDED RELEASE;ORAL - 12.5MG Sponsor LEO PHARM Submission history Latest submission status date: 1989-12-28 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.